相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Continuous Renal Replacement Therapy-Related Strategies to Avoid Colistin Toxicity: A Clinically Orientated Review
Patrick M. Honore et al.
BLOOD PURIFICATION (2014)
Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model
Zohra Ghlissi et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Systematic review of the evidence for rational dosing of colistin
E. Visser Kift et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2014)
Early Prediction of Polymyxin-Induced Nephrotoxicity With Next-Generation Urinary Kidney Injury Biomarkers
Natalie D. Keirstead et al.
TOXICOLOGICAL SCIENCES (2014)
How Does Colistin-Induced Nephropathy Develop and Can It Be Treated?
Gulsum Ozkan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
Luisa Sorli et al.
BMC INFECTIOUS DISEASES (2013)
Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin
Linda Shavit et al.
CLINICAL NEPHROLOGY (2013)
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii
Sonia Luquea et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Evaluation of colistin nephrotoxicity administered at different doses in the rat model
Zohra Ghlissi et al.
RENAL FAILURE (2013)
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
Monica Rocco et al.
CRITICAL CARE (2013)
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Diana F. Florescu et al.
CLINICAL INFECTIOUS DISEASES (2012)
Closing the Loop-A Colistin Clinical Study to Confirm Dosing Recommendations From PK/PD Modeling
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2012)
High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2012)
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
Gamze Kalin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats
Jumana M. Yousef et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?
Ezgi Ozyilmaz et al.
INTENSIVE CARE MEDICINE (2011)
Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis
Nadira Durakovic et al.
INTERNAL MEDICINE (2011)
Risk factors for colistin-associated nephrotoxicity
Pinyo Rattanaumpawan et al.
JOURNAL OF INFECTION (2011)
Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
Hee ja Ko et al.
NEPHRON CLINICAL PRACTICE (2011)
Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients
Neha M Doshi et al.
PHARMACOTHERAPY (2011)
Hemodynamic parameters to guide fluid therapy
Paul E. Marik et al.
ANNALS OF INTENSIVE CARE (2011)
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
Argyris S. Michalopoulos et al.
ANNALS OF INTENSIVE CARE (2011)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Predictors of acute kidney injury associated with intravenous colistin treatment
Jeong-Ah Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lauren M. Lim et al.
PHARMACOTHERAPY (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Early Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers
Sachin S. Soni et al.
BLOOD PURIFICATION (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Colistin in the 21st century
Roger L. Nation et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
POLYMYXINS - REVIEW WITH EMPHASIS ON NEPHROTOXICITY
Carlos Alberto Caldeira Mendes et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2009)
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative, bacteria
Vicente Pintado et al.
JOURNAL OF INFECTION (2008)
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Alex P. Betrosian et al.
JOURNAL OF INFECTION (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
Hatem Kallel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia
Peter K. Linden et al.
CLINICAL INFECTIOUS DISEASES (2006)
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria
J Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2003)
分享论文
